IFG
AQST icon

Independent Financial Group’s Aquestive Therapeutics AQST Stock Holding History

Independent Financial Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,750
Closed -$65.4K – 1554
2026
Q1 		$65.4K Sell
15,750
-5,700
-27% -$23.1K ﹤0.01% 1433
2025
Q4 		$139K Buy
+21,450
New +$134K ﹤0.01% 1369

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Independent Financial Group's AQST Position: Q2 2026 in Review

Independent Financial Group sold out of Aquestive Therapeutics (AQST) in Q2 2026, closing a stake of 15,750 shares — an estimated $65.4K sold.

Independent Financial Group first reported a position in AQST in Q4 2025 and held it in 2 quarters. The position peaked at $139K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Independent Financial Group reported no remaining Aquestive Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Independent Financial Group sold 15,750 Aquestive Therapeutics shares in Q2 2026, an estimated $65.4K.
  • Independent Financial Group first reported a position in Aquestive Therapeutics in Q4 2025 and held it in 2 quarters.
  • Independent Financial Group's Aquestive Therapeutics position peaked at $139K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.